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MORATORIA IN SCIENTIFIC
RESEARCH: A REVIEW
VALERIE BONHAM *
“Whatever you do, don’t recommend a moratorium.”
So urged a very senior scientist as I worked with President Obama’s
Bioethics Commission in 2010 on its first project: examining synthetic biology
following the creation of a self-replicating bacterial cell with a whollysynthesized genome. 1 Spoken from many decades of experience in the “science
wars” of national debate surrounding controversial research activities, these
remarks came across with inescapable urgency. A moratorium, that is, a
suspension of federal funding, or some other legal prohibition or censure, even
if temporary, would slow research progress. Further, even if temporary, it could
affect public perception and support for scientific exploration for years, even
decades. The modern scientific landscape since the 1970s has seen multiple
moratoria, usually based on ethical concerns about controversial scientific
endeavors. But, the appeal of a moratorium is understandable, particularly when
ethical concerns cannot otherwise be resolved or sufficiently managed.
In June 2019 President Trump announced a moratorium on federal funding
for research involving fetal tissue derived from elective abortions. 2 For many,
© 2021 Valerie Bonham
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1. Presidential Commission for the Study of Bioethical Issues, New Directions: The Ethics of
Synthetic Biology and Emerging Technologies, BIOETHICS.GOV,
https://bioethicsarchive.georgetown.edu/pcsbi/synthetic-biology-report.html (last updated Jan. 17,
2017).
2. Amy Goldstein, New Restriction on Fetal Tissue Research ‘Was the President’s
Decision’, WASH. POST (Jun. 5, 2019, 3:03PM), https://www.washingtonpost.com/health/trumpadministration-imposes-new-restrictions-on-fetal-tissue-research/2019/06/05/b13433c0-8709-11e9a491-25df61c78dc4_story.html.
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this felt like Groundhog Day. Research with fetal tissue has been a political
football in the United States for decades. 3 While politicians were divided over
this action and the scientific community was generally opposed, proponents saw
it as a triumph for bioethics, as they understand it. To its supporters, banning
this research was ethically warranted and justified, even mandatory. To at least
some of its opponents, the ban was a crass attempt to curry favor with fickle or
ill-informed voting blocs. 4 Undoubtedly, it will slow some types of research
advances or developments. President Biden may overturn the Trump policy (as
of this writing that has not happened) easily enough through direction to the
Secretary of Health and Human Services (“HHS”). Indeed, the Secretary could
reverse the policy without Presidential direction. But reversing it, no matter how
easy it is a technical matter, will surely carry public attention and stir debate.
Law is often a blunt instrument for bioethical issues (and other issues) at
the intersection of science and society. Moratoria are quite blunt. They are also
headline-grabbing, seemingly an “active” response to complex issues, and a tool
to enable those who propose them to say that they are doing something.
Unfortunately, they can be hard to un-do, even when they arise from
discretionary policy rather than law or regulation. To facilitate discussion and
illuminate how moratoria have been used in modern times, this article compiles
a brief history of scientific moratoria with bioethics implications over the past 45
years, going back to the watershed Asilomar conference that followed from a
voluntary moratorium on gene research in the early 1970s. 5 The Appendix
includes a table summarizing selected moratoria. 6 The article discusses
legislative and executive policy moratoria on the national level, and voluntary
moratoria on the international level. Absent from the discussion are moratoria
based on state or local statutes, regulation, and policy. Thus, the discussion is
not a complete inventory. Instead, the article aims to be a resource and highlight
some interesting and informative examples. The selection seeks to highlight
experience and spark discussion about when moratoria do and do not make sense,
and hopefully uncover the reasons behind these conclusions. For future
policymakers, ethics committees, legislators, and regulators, it will be useful to
consider this history carefully before enacting moratoria.

3. Debra Goldschmidt & Susan Scutti, Trump Administration Limits Research Using Fetal
Tissue, CNN HEALTH, https://www.cnn.com/2019/06/05/health/hhs-fetal-tissue-research-bn (last
updated Jun. 5, 2019, 4:26PM).
4. See, e.g., The Times Editorial Board, Editorial, Trump’s Fetal Tissue Bane Will Hurt Many
More Babies Than it ‘Saves,’ L.A. TIMES (Jun. 7, 2019, 3:05AM),
https://www.latimes.com/opinion/editorials/la-ed-fetal-tissue-ban-trump-20190607-story.html (arguing
the moratorium will stall research in several areas).
5. Adam Briggle, Asilomar Conference,
ENCYCLOPEDIA.COM, https://www.encyclopedia.com/science-and-technology/biology-andgenetics/cell-biology/asilomar-conference (last updated Aug 13, 2018).
6. See infra Appendix: Selected Moratoria.
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I. MORATORIA, GENERALLY
What exactly qualifies as a moratorium and how does it differ from a ban?
The Merriam-Webster Dictionary defines a moratorium as either a “suspension
of activity,” “legally authorized period of delay in the performance of a legal
obligation or the payment of a debt,” or “waiting period set by an authority.” 7 In
each instance, a moratorium is demarcated by its impermanent nature. 8 A
moratorium, by its nature, should not last forever. On the other hand, a ban is
defined as a “legal or formal prohibition.” 9 Inherent in its definition, a ban has
permanence baked into it. However, the use of moratoria and bans in science
has not neatly complied with the distinct nature of the definitions of moratoria,
as temporary prohibitions, and bans, as permanent ones. For example, as
described in greater detail in this paper, a 1988 moratorium on transplantation
research with human fetal tissue from induced abortions was supposed to end
when a panel issued a report within the same year. 10 After its report, the
moratorium was extended indefinitely and was not repealed until 1993; this
moratorium lasted five years. 11 In contrast, in 2019, HHS banned the purchase
and use of human fetal tissue by National Institutes of Health (“NIH”)
scientists. 12 This executive policy ban is susceptible to change by the Biden
Administration. If so, the “ban” would have lasted for no more than a three-year
period – notably shorter than the five-year moratorium of the late 1980s. Even
more distinct, the Dickey-Wicker ban must receive regular renewal because it
was a rider to a larger piece of legislation. 13 Such regular renewal is hardly
reflective of the permanent nature of a ban. Therefore, while some may thread
the needle on the difference between a moratorium and ban, we use the two
interchangeably for the purposes of this article, consistent with our observations
on the practical applications of both terms.

7. Moratorium, MERRIAM-WEBSTER DICTIONARY, https://www.merriamwebster.com/dictionary/moratorium (last visited Apr. 6, 2021).
8. Reetika Wadhwa & Nishtha Das, Moratorium: Meaning and Relief Measures Introduced by
RBI Amid Covid-19, LEXOLOGY.COM (Apr. 17,
2020), https://www.lexology.com/library/detail.aspx?g=7aa5bda5-e108-4a0f-99a2-0f8cefeb70df.
9. Ban, MERRIAM-WEBSTER DICTIONARY, https://www.merriam-webster.com/dictionary/ban (last
visited Apr. 6, 2021).
10. See James F. Childress, Deliberations of the Human Fetal Tissue Transplantation Research
Panel, in BIOMEDICAL POLITICS 215, 216, 218 (Kathi E. Hanna ed., 1991), for greater detail on the 1988
research.
11. Helen M. Maroney, Bioethical Catch-22: The Moratorium on Federal Funding of Fetal Tissue
Transplantation Research and the NIH Revitalization Amendments, 9 J. CONTEMP. HEALTH L. & POL’Y
485, 487 (1993).
12. Human Fetal Tissue Research: Frequently Asked Questions, CONG. RSCH. SERV.
https://fas.org/sgp/crs/misc/R44129.pdf (last updated Aug. 8, 2019).
13. Nidhi Subbaraman, Research on Embryo-like Structures Struggles to Win US Government
Funding, NATURE (Jan. 17, 2020), https://www.nature.com/articles/d41586-020-00127-z.
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Experts can debate the taxonomy, but we see three main types of moratoria:
(1) those imposed legislatively, e.g., the Dickey-Wicker amendment, be they
through appropriations or other legislation; (2) those created by government
policy, e.g., stem cells, the White House’s recent fetal tissue ban, and the NIH’s
chimera policy; and (3) those arising voluntarily from the scientific community,
e.g., from Asilomar and more recently on germline-editing through CRISPRCas9. 14
The origin and authority of a moratorium matter.
They affect
enforceability, penalties, reach, and impact. Legislative moratoria can only be
removed by additional legislation or failure to approve statutory amendments or
riders. 15 Executive policy moratoria may be lifted by revision to federal rules
after a public comment period or repeal of a memorandum, as applicable. 16
Voluntary moratoria are overcome after community consensus has been reached
on its dissolution, often after the adoption of community standards on conduct. 17
II. LEGISLATIVE MORATORIA
Of the three types of moratoria discussed in this paper, legislative moratoria
are the most powerful but also the most intractable. Legislative moratoria are
established through the passage of legislation through Congress. 18 These types
of moratoria carry the full weight of the legislative branch, and, where Congress
requires, executive policy must comply with its prohibitions. 19
This power, however, comes with a trade-off: legislative moratoria cannot
be instituted as quickly as other types of moratoria in response to an ethics
emergency due to the nature of the deliberative process involved in legislating. 20
To succeed in passage, advocates of a moratorium must convince hundreds if not
thousands of members of Congress, staff persons, lobbyists, and constituents to
spend capital to realize their goal. Once passed, repeal of the legislative
moratoria can be just as difficult – marshalling all the resources of individuals
and organizations advocating for their interests for or against the moratorium.
Perhaps the most famous legislative moratorium in research is the DickeyWicker Amendment.

14. See Russell A. Spivak et al., Moratoria and Innovation in the Reproductive Science: of Prext,
Permanence, Transparency, and Time Limits, 14 J. HEALTH & BIOMEDICAL L. 5, 6 (2018) (describing
four types of moratoria, drawing a distinction between statutory moratoria that arise in appropriations
law and require annual renewal and statutory moratoria that are permanent until repealed).
15. Id.
16. Id.
17. Id. at 26.
18. See id. at 6.
19. Id. at 10–11.
20. Id. at 26
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a. Dickey-Wicker Amendment
In 1994, the NIHHuman Embryo Research Panel, which was assembled to
evaluate when human embryo research should be federally funded, published
their report. 21 In it, the panel recommended that the creation of embryos for
research purposes should be permitted under certain circumstances. 22 While
President Clinton accepted some of the panel’s recommendation, he rejected this
one.
In response, 23 in 1995 Congress passed an appropriations bill rider as an
amendment to a bill, often referred to as the Dickey-Wicker Amendment after its
congressional sponsors. 24 The amendment, which has been renewed regularly
since original introduction, prohibits HHS from using federal funds for:
(1) [T]he creation of a human embryo or embryos for research
purposes; or
(2) [R]esearch in which a human embryo or embryos are destroyed,
discarded, or knowingly subjected to risk of injury or death greater
than that allowed for research on fetuses in utero . . .” 25
Human embryo was defined to include “any organism . . . that is derived by
fertilization, parthenogenesis, cloning, or any other means from one or more
human gametes or human diploid cells.” 26
Dickey-Wicker is a statutory limit from which there is no flexibility. 27
Consequently, the law is incorporated as a term and condition of award in the
NIH Grants Policy Statement, which defines the terms and conditions under
which NIH determines who receives federal funding research grants; all funding

21. See HAROLD VARMUS, THE ART AND POLITICS OF SCIENCE 197–98 (2009).
22. Id. at 199.
23. Marlene Cimons & Jonathan Peterson, Clinton Bans U.S. Funds for Human Closing Research;
Science: He Urges Private Sector to Refrain From Such Experiments, Warns of New Ethical Burdens.
The Federal Agency that Provide Money Doesn’t Support Any Projects, L.A. TIMES (Mar. 5, 1997),
https://www.latimes.com/archives/la-xpm-1997-03-05-mn-35032-story.html. Note that, in 1994,
President Clinton banned the use of federal funds to support the creation of human embryos solely for
research purposes; this is an example of an executive policy ban that we will not delve into in the course
of this article.
24. The Balanced Budget Downpayment Act, Pub. L. No. 104–99, § 128, 110 Stat. 26, 34 (1996).
25. Omnibus Appropriations Act of 2009, Pub. L. No. 111–8, § 509, 123 Stat. 524, 534 (1996).
26. Katrien Devolder, What’s In A Name? Embryos, Entities, and ANTities In The Stem Cell
Debate, 32 J. MED. ETHICS 43, 45 (2006).
27. Omnibus Appropriations Act of 2009, Pub. L. No. 111–8, § 509, 123 Stat. 524, 534 (1996).
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recipients must comply. 28 This means that there are individuals at NIH who
spend a lot of time and effort navigating how to apply the law to ensure that
neither intramural nor extramural funds are expended on any research that would
violate the Dickey-Wicker prohibition. 29
Violations of the prohibition materialize in a number of ways: (1) NIH
could intentionally or unintentionally allocate federal funds to research used in
the creation of a human embryo, or (2) an NIH grant recipient could mislead NIH
on the goal or process of its study to receive funds and apply those funds. 30
However, statutory requirements come with heavy penalties and are
enforceable in concrete ways that voluntary moratoria are not. Anyone who does
violate the law faces a loss of funding and possible restrictions on future research
activities, and, at least theoretically, could face more severe penalties if the action
were deemed an intentional effort to violate the law or the terms and conditions
of funding, including the imposition of civil monetary penalties. 31
This Amendment has been in place for well over twenty years with
essentially zero legislative or public debate since its inception. 32 The absence of
debate related to its renewal indicates the broad consensus held in Congress to
maintain, or at least not repeal, the Dewey-Wicker prohibition. 33 It illustrates
also how difficult reversing legislative moratoria can be.
III. EXECUTIVE POLICY MORATORIA
Executive branch and agency moratoria are more flexible in comparison to
legislative moratoria. Rather than seeking the approval of a majority of Congress
– potentially hundreds of people – an executive policy moratorium may be
overturned with the change of administrations in the White House or with the
change of individuals within an agency. Additionally, they may be more
susceptible to outside influence through the notice and public comment process.
However, executive policy moratoria tend to have limited scope. Where
legislative moratoria may be expansive, limited only by the Congress’
constitutional limitations and its own imagination, all executive policy must be
founded in authorizations provided by legislation and limits on the powers of any
28. The Witherspoon Council, Stem Cell Research Funding: Policy and Law, NEW ATLANTIS,
(2012), https://www.thenewatlantis.com/publications/appendix-d-stem-cell-research-funding-policyand-law.
29. David G. Zacharias et al., Impedance of Novel Therapeutics Technologies: The Case of Stem
Cells, 5 CLINICAL & TRANSLATIONAL SCI. 422, 423–24 (2012) (discussing the political and legal battle
between the NIH and the Dickey-Wicker Amendment).
30. 42 U.S.C.A. § 289g.
31. Omnibus Appropriations Act of 2009, Pub. L. No. 111–8, § 509, 123 Stat. 524, 534 (2009).
32. Kirsten R.W. Matthews & Daniel Morali, National Human Embryo and Embryoid Research
Policies: A Survey of 22 Top Research-Intensive Countries, 15 REGENERATIVE MED. 1905, 1908 (2020).
33. See id. at 1909 (stating that there has been no change either legislatively or judicially since the
Amendment was passed).
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given agency. For example, NIH moratoria often appear in the form of a ban on
funding because NIH has the authority to draft grant funding guidelines. 34
a. Chimeras Research
Over the past two decades, an increasing number of researchers have been
interested in experiments involving human and animal genetic mixing where
human stem cells were being placed into non-human animal embryos. 35 The
increased demand in growing human tissue in organs of animals alarmed NIH.
In 2009, NIH published its Guidelines on Human Stem Cell Research, 36 pursuant
to an executive order by President Obama. 37 The guidelines established a policy
and procedure in which NIH would fund human stem cell research in an ethically
responsible and scientifically worthy way. 38 However, the guidelines also
prohibited the use of NIH funds for introducing human stem cells into early-stage
embryos of non-human primates. 39
As researchers discovered new stem cell research opportunities, NIH
became concerned about some scientists growing human tissue and organs in
animals by introducing human stem cells into early stage non-human vertebrate
embryos. 40 Consequently, in 2015 the NIH announced, effective as of the date
of the announcement, that it would not fund “any new or competing grant
applications or contract proposals for research in which human pluripotent cells
are introduced into non-human vertebrate animal pre-gastrulation stage
embryos.” 41 The agency explained at the time the moratorium was implemented
that the agency could “undertake a deliberative process to evaluate the state of
the science in this area, the ethical issues that should be considered, and the
relevant animal welfare concerns associated with these types of studies.” 42
34. See, e.g., NAT’L INST. OF PUB. HEALTH, NOT-OD-15-158: NIH RESEARCH INVOLVING
INTRODUCTION OF HUMAN PLURIPOTENT CELLS INTO NON-HUMAN VERTEBRATE ANIMAL PREGASTRULATION EMBRYOS (2015); and NAT’L INST. OF PUB. HEALTH, NOT-OD-17-071: NOTICE
ANNOUNCING THE REMOVAL OF THE FUNDING PAUSE FOR GAIN-OF-FUNCTION RESEARCH PROJECTS
(2017).
35. Nicholas Wade, New Prospects for Growing Human Replacement Organs in Animals, N.Y.
TIMES (Jan. 26, 2017), https://www.nytimes.com/2017/01/26/science/chimera-stemcells-organs.html.
36. National Institutes of Health Guidelines for Human Stem Cell Research, 74 Fed. Reg. 128 (Jul.
7, 2009).
37. Exec. Order No. 13505, 3 C.F.R. § 13505 (2009).
38. NAT’L INST. OF PUB. HEALTH, NATIONAL INSTITUTES OF HEALTH GUIDELINES FOR HUMAN
STEM CELL RESEARCH (2009).
39. Id.
40. Rob Stein, Should Human Stem Cells Be Used To Make Partly Human Chimeras?, NPR (Nov.
6, 2015, 3:39 AM), https://www.npr.org/sections/health-shots/2015/11/06/454693391/should-humanstem-cells-be-used-to-make-partly-human-chimeras.
41. NAT’L INST. OF HEALTH, NOT-OD-15-158, NIH RESEARCH INVOLVING INTRODUCTION OF
HUMAN PLURIPOTENT CELLS INTO NON-HUMAN VERTEBRATE ANIMAL PRE-GASTRULATION EMBRYOS
(2015).
42. Id.
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As part of its policy-making process, the agency held an experts’ workshop
in 2015 to discuss the research and animal welfare issues. 43 The workshop
identified a clear interest in producing animal models with human tissues or
organics for several opportunities, including organ transplantation. 44 It also
convened an internal “steering committee” to develop recommendations for NIH
leadership and “monitor trends in this general field of research and the use of
new technologies.” 45
A year after announcing the chimera moratorium, the NIH requested
comment on its thinking, expressly citing the potential benefits of the research. 46
Thereafter, it signaled its intent to lift the ban, with certain conditions. 47 But,
that did not happen and the moratorium remains in place. 48 Notably, while NIH
intends to end the moratorium on chimera research, it has requested comments
on its proposal to expand the 2009 Guidelines prohibition against stem cell use
in non-human primate embryos. 49
Unlike some past actions, the chimera moratorium arose in the modern era
of notice and comment policymaking, with social media and technology-enabled
advocacy available to influence or drive policymaker’s actions. 50 Moreover,
similar to stem cell research and anything that touches on the politics of human
conception in the United States, this issue garnered interest from passionate
constituencies interested in animal welfare and rights as well as those interested
more generally in research and scientific advancement. 51
Since then, it is not clear when, or how, the moratorium may be lifted, nor
is it clear by what criteria NIH will make this choice. Because the ban is agencyimposed and discretionary, it can be lifted with little fanfare or process. But, the
failure to lift it tells us something about the risks that can attach to a moratorium.
43. Carrie D. Wolinetz, Next Steps on Research Using Animal Embryos Containing Human Cells,
NAT’L INST. OF HEALTH: OFF. OF SCI. POL’Y (Aug. 4, 2016), https://osp.od.nih.gov/2016/08/04/nextsteps-on-research-using-animal-embryos-containing-human-cells/.
44. Id.
45. NAT’L INST. OF HEALTH, NOT-OD-16-128, REQUEST FOR PUBLIC COMMENT ON THE
PROPOSED CHANGES TO THE NIH GUIDELINES FOR HUMAN STEM CELL RESEARCH (2016).
46. Id.
47. Jocelyn Kaiser, NIH Plans to Fund Human-Animal Chimera Research, SCIENCE MAG, Aug. 12,
2016, at 643.
48. Omnibus Appropriations Act of 2009, Pub. L. No. 111–8, § 509, 123 Stat. 524 (2009).
49. Request for Public Comment on the Proposed Changes to the NIH Guidelines for Human Stem
Cell Research and the Proposed Scope of an NIH Steering Committee’s Consideration of Certain
Human- Animal Chimera Research, 81 Fed. Reg. 51921 (Aug. 5, 2016). The Guidelines currently
prohibit the use of stem cell research with blastocyste stage nonhuman primate embryos. Id. The
proposal would include pre-blastocyst stage embryos. Id.
50. Douglas Yeung, Social Media as a Catalyst for Policy Action and Social Change for Health
and Well-Being: Viewpoint, 20 J. MED. INTERNET RSCH. 1, 2 (2018).
51. Carolyn Plunkett Neuhaus, Get the Public Involved in Chimera Research at NIH,
BIOETHICS.NET (Aug. 15, 2016, 10:48), http://www.bioethics.net/2016/08/get-the-public-involved-inchimera-research-at-nih/.
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Having announced the need to prohibit funding in this area of science, pending
further deliberation, the agency is faced now with the challenge of backpeddling. The rules, procedures, and rationale attached the termination of the
chimera moratorium will be widely scrutinized and will need to meet the serious
concerns raised to justify its imposition in the first place. It is not that it cannot
be done. In fact, the experience with recombinant DNA as described below,
among other examples, shows that the agency can and does evolve its thinking
over limits on research activities in light of changing circumstances and mores.52
b. Chimpanzees in Research
The interest in animal welfare was not restricted to the chimera research
moratorium. At that time, animal welfare issues were at the forefront of the
agency’s thinking. 53 In 2011, NIH announced new requirements on the use of
research involving chimpanzees requiring that these protocols satisfy certain
ethical criteria, namely:
1. That the knowledge gained must be necessary to advance the
public’s health;
2. There must be no other research model by which the knowledge
could be obtained, and the research cannot be ethically performed on
human subjects; and
3. The animals used in the proposed research must be maintained
either in ethologically appropriate physical and social environments
(i.e., as would occur in their natural environment) or in natural
habitats. 54
Following that, in 2013 NIH announced a reduction in its use of NIH-owned or
supported chimpanzees in NIH-funded research. 55 Dr. Collins, then Director of
NIH stated, “I am confident that greatly reducing [chimpanzee] use in biomedical

52. See, e.g., 84 Fed. Reg. 17858 (Apr. 26, 2019) (demonstrating that the NIH Guidelines occupy a
unique space in the administrative framework, whereby regulations are not promulgated through notice
and comment rulemaking in the conventional sense of informal rulemaking); see also NAT’L INST. OF
HEALTH, NIH GUIDELINES (April 2019), https://osp.od.nih.gov/wpcontent/uploads/NIH_Guidelines.pdf.
53. NAT’L INST. OF HEALTH, STATEMENT BY NIH DIRECTOR DR. FRANCIS COLLINS ON THE
INSTITUTE OF MEDICINE REPORT ADDRESSING THE SCIENTIFIC NEED FOR THE USE OF CHIMPANZEES IN
RESEARCH (2011).
54. Id.
55. NAT’L INST. OF HEALTH, NIH TO REDUCE SIGNIFICANTLY THE USE OF CHIMPANZEES IN
RESEARCH (2013).
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research is scientifically sound and the right thing to do” in accepting an NIHcommissioned study’s recommendations. 56
Shortly after announcing the chimera ban and consistent with its 2013
announcement on chimpanzee use in NIH research, the agency also announced
an unprecedented decision to ban the use of the remaining NIH-owned and
supported chimpanzees for research. 57 This ban was more significant than the
2013 limits on NIH-owned chimpanzees as well as the 2009 Guidelines, which
merely banned use of stem cells in non-human primate embryos. In making this
announcement, the NIH Director explained: “It is clear that we’ve reached a
tipping point” in the need for, and social acceptability of, using chimpanzees in
research. 58
As such, the ban on chimpanzees in research is a valuable story of policy
change and use of a moratorium to advance an ethical goal, albeit within the
somewhat limited realm of NIH-funded research.
c. Human Fetal Tissue Research
Human fetal tissue is used in scientific research in a range of ways such as
vaccine development, stem cell research and transplantation, and chimeras.
Historically, its use has been controversial because human fetal tissue is often
collected from a still-born fetus or as a result of an abortion procedure. 59 The
history of human fetal tissue research moratoria, restrictions, and prohibitions is
a clear example of how scientific processes can be curtailed and limited by the
influence of partisan social issues such as abortion.
Between 1974 and 1975, federal funds were prohibited from being used on
research involving living fetuses while the National Commission for the
Protection of Human Subjects of Biomedical and Behavioral Research studied
the issue. 60 In 1975, the moratorium was lifted as the Commission released its
report, concluding that such research was acceptable, and provided proper safety
protocols and oversight. 61 Shortly thereafter, the federal government published
regulations adopting the recommendations of the Commission. 62

56. Id.
57. NAT’L INST. OF HEALTH, NIH WILL NO LONGER SUPPORT BIOMEDICAL RESEARCH ON
CHIMPANZEES (2015).
58. Id.
59. Heather D. Boonstra, Fetal Tissue Research: A Weapon and a Casualty in the War Against
Abortion, 19 GUTTMATCHER POL’Y REV. 9, 11 (2016).
60. ERIN D. WILLIAMS, CONG. RSCH. SERV., FEDERAL PROTECTION FOR HUMAN RESEARCH
SUBJECTS 14 (2005).
61. NAT’L COMM’N FOR THE PROT. OF HUM. SUBJECTS OF BIOMEDICAL AND BEHAV. RSCH,
RESEARCH. ON THE FETUS 63 (1975).
62. Fetuses, Pregnant Women, In Vitro Fertilization, 40 Fed. Reg. 33,526 (Aug. 8, 1975) (to be
codified at 45 C.F.R. pt. 46).
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However, the regulations led to an inadvertent moratorium in a limited
circumstance: research on a fetus in utero. 63 The regulations required that
research involving a fetus in utero must involve minimal risk. 64 Whether risk
associated with any particular research was minimal or otherwise was not
defined. A Congressionally mandated Ethics Advisory Board (“EAB”), formed
to study the ethics of human embryo research, had authority to interpret and
provide waivers for experiments that were risky. 65 From 1975 to 1980, the EAB
did not issue a single waiver and was disbanded in 1980 for unrelated reasons,
thereby depriving researchers who hoped to conduct research using a fetus in
utero from an assessment or waiver related to the level of risk associated with a
study. This created a de facto moratorium on such research that would last
through interagency and political fights that would not be overcome until 1993. 66
At the same time, in 1988, HHS sent a memorandum to NIH imposing a
moratorium on transplantation research with fetal tissue from induced abortions
until the Human Fetal Tissue Transplantation Research Panel issued a report –
which it did in December 1988. 67 The Panel reported a number of
recommendations that were endorsed by the Advisory Committee to the Director
of NIH, including a lift of the moratorium in place. 68 Despite the
recommendation to lift the moratorium, HHS extended the moratorium
indefinitely afterwards due to the politically partisan connection to the abortion
debate in the 1980s in the Reagan and Bush administrations. 69
Congress expressly authorized the use of human fetal tissue to be used in
research when it passed the National Institutes of Health Revitalization Act of
1993. 70 It defined “human fetal tissue” as tissue or cells obtained from a dead
human embryo or fetus after a spontaneous or induced abortion, or after a
stillbirth. 71 The statute permits fetal tissue research regardless of whether the
tissue is obtained from a spontaneous or induced abortion or because of a
stillbirth so long as certain conditions are met. 72
63. 45 C.F.R. § 46.204 (1975).
64. Id. § 46.116(d)(1) (stating that the IRB can approve a procedure if “the research involves no
more than minimal risk to the subjects.”).
65. Id. § 46.207; Fetuses, Pregnant Women, In Vitro Fertilization, 40 Fed. Reg. 33,526, 33,529
(Aug. 8, 1975) (to be codified at 45 C.F.R. pt. 46).
66. Meredith Wadman, Senate Panel Seeks Middle Ground on Human Fetal Tissue Research and
Abortion, SCI. MAG. (Sept. 8, 2017 1:45 PM), https://www.sciencemag.org/news/2017/09/senate-panelseeks-middle-ground-human-fetal-tissue-research-and-abortion.
67. Childress, supra note 10.
68. HUM. FETAL TISSUE TRANSPLANTATION RSCH. PANEL, REPORT OF THE ADVISORY COMMITTEE
TO THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH 6 (1988).
69. Maroney, supra note 11, at 485–86.
70. National Institutes of Health Revalorization Act of 1993, Pub. L. No.103–43, § 111–14, 107
Stat 122, 129–33 (codified as amended at 42 U.S.C. § 289g-1).
71. Id.
72. 42 U.S.C. § 289g-1 (1944).
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Congressional approval of the use of human fetal tissue in research,
however, did not end concerns on the practice. In December 2018 HHS ordered
Food and Drug Administration (“FDA”) and NIH researchers to stop purchasing
fetal tissue. 73 The prohibition was part of a broader move under President
Trump’s administration to prohibit or minimize the use of human fetal tissue.74
In 2018, HHS also refused to renew on an annual basis a research contract with
the University of California San Francisco that involved use of human fetal
tissue; it elected to renew it for 90-day periods at a time. 75 HHS also canceled
another contract between the FDA and a third party for the human of human fetal
tissue from elective abortions. 76 The cancelations were followed by a ninemonth review of all of HHS’ research involving human fetal tissue from elective
abortions. 77 In June 2019, HHS announced that it would not extent the UCSF
contract. 78 At the same time HHS also announced that intramural research using
human fetal tissue would not be funded and extramural research would be subject
to a lengthy, time-consuming additional review process by an ethics board. 79
Some have viewed the additional ethics board review as a deliberate
attempt to restrict, delay, or deny the use of human fetal tissue in research. If
effective, the additional burden on already complicated NIH grant application
and review processes may result in a de facto moratorium of NIH funding on all
human fetal tissue research. The policy may have short- to medium-term impact
on research that utilizes human fetal tissue as applicants consider whether the
additional delay in time and resources is worthwhile and alternative routes are
available to avoid the use of human fetal tissue. However, the long-term impact
may be limited because of the nature of executive policy moratoria. Under the
Biden Administration, the policy may be overturned, and NIH may contract with
organizations that conduct research using human fetal tissue and may alleviate
the process burdens associated with grant funding of research that uses the same.

73. Denise Grady, Fetal Tissue Research is Curtailed by Trump Administration, N.Y. TIMES (Dec.
12, 2018, 11:59), https://www.nytimes.com/2018/12/12/health/fetal-tissue-research-trump.html.
74. Id.
75. Id.
76. Id.
77. Establishment of Safeguards and Program Integrity Requirements for Health and Human
Services-Funded Extramural Research Involving Human Fetal Tissue, 86 Fed. Reg. 2615, 2615 (Jan. 13,
2021) (to be codified at 45 C.F.R. pts. 46, 75).
78. DEP’T OF HEALTH & HUM. SERV., STATEMENT FROM THE DEPARTMENT OF HEALTH AND
HUMAN SERVICES (2019), https://www.hhs.gov/about/news/2019/06/05/statement-from-the-departmentof-health-and-human-services.html.
79. Id.
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d. Human Cloning Research
In 1997, a Scottish scientist announced the successful creation of a baby
sheep cloned using genetic materials from an adult sheep named Dolly. 80 That
same year, researchers in Oregon successfully cloned two monkeys. 81 These
stories caught the attention of major media outlets and were reported on across
the nation and the globe. Fear and controversy surged. Subsequently, President
Clinton issued a ban on the use of federal funds for human cloning research. 82
As already noted, however, Congress had previously prohibited the funding for
human embryo research, indirectly prohibiting human cloning. 83 Additionally,
in 1994 the President had banned the use of federal funds to support the creation
of human embryos solely for research purposes. 84 Thus, the President’s 1997
executive policy was intended to close any loopholes in the law. 85 In justifying
the ban, the President stated: “Science often moves faster than our ability to
understand its implications . . . . That is why we have a responsibility to move
with caution and care.” 86
The President’s ban on human cloning research provides a prime example
of a prohibition driven, at least in part, by the need to address and alleviate the
public’s concerns related to the rapid development of controversial scientific
technology and its longer-term ramifications. In commenting on the President’s
ban, then NIH Director, Harold Varmus, stated that the policy was an attempt to
provide reassurance to the public that federal funds were not used for human
cloning. 87 Additionally, Director Varmus hoped it would “calm people’s fears
about those nightmarish possibilities that are extremely unlikely, and get them to
focus on the real dilemmas.” 88
The Clinton cloning policy continues and, at least as of this writing, faces
few objections. Perhaps this is because the collective public opposition to human
cloning, including from within the scientific community, is widely shared across
the political spectrum. 89

80. Cimons & Peterson, supra note 23.
81. Id.
82. Id.; Memorandum on the Prohibition on Federal Funding for Cloning of Human Beings, 1 PUB
PAPERS 233 (Mar. 4, 1997).
83. Cimons & Peterson, supra note 23
84. Id.
85. Id.
86. Presidential Remarks Announcing the Prohibition on Federal Funding for Cloning of Human
Beings and an Exchange with Reporters, 33 WEEKLY COMP. PRES. DOC. 21 (Mar. 4, 1997).
87. Cimons & Peterson, supra note 80.
88. Id.
89. See David Masci, 20 Years After Dolly theSheep’s Debut, Americans Remain Skeptical of
Cloning, PEW RSCH. (Feb. 22, 2017), https://www.pewresearch.org/fact-tank/2017/02/22/20-years-afterdolly-the-sheeps-debut-americans-remain-skeptical-of-cloning/ (describing public opinion about cloning
between 1997-2017).
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IV. VOLUNTARY MORATORIA
Unlike legislative or executive policy moratoria, a voluntary moratorium
that the scientific community imposes upon itself does not pose the risk of losing
government funding or other threats arising from the power of the state. The
penalty in such cases arises from community censure. This could include the
loss of publication opportunities, for example where a journal decides not to
publish a researcher’s paper because the research violates a community standard,
or the threat to employment in the event that a community moratorium is adopted
as a matter of policy within an institution such as a research university or medical
center. 90 Furthermore, depending on the scale of the violation and the degree of
consensus within the community calling for the moratorium, an individual could
face long-term threats to career advancement, and other more subtle actions that
enable censure from the professional community of scientists to carry weight
beyond, and materially different from, a legislative mandate.
a. Asilomar and Its Sequelae
The Asilomar story is a widely known example of the community of
scientists coming together to self-censure and limit research until a consensus
surfaces around how to proceed with an uncertain field of scientific inquiry. 91
Prior to 1975, molecular biologists conducted research on the relatively new
discovery of DNA, as revealed to the world in 1953. 92 In the more than twenty
years after its discovery researchers were entering a whole new world of
possibilities with the development around recombinant DNA. 93 Recombinant
DNA was DNA molecules formed artificially in a lab by combing genetic
material from different organisms to form a DNA sequence that would not have
otherwise been found. 94
Worried about potential for harm in the experiments they were performing,
researchers in the very early years of recombinant DNA research asked the
National Academy of Sciences for guidance. 95 Additionally, public anxiousness
about the ramifications of the research was on the rise as the media began to tell

90. See Charlene Kalebic, The Constitutional Question of Cloning Humans: Duplication or
Procreation? An Examination of the Constitutional Right to Procreate, 8 S. CAL. INTERDISC. L.J. 229,
248, 278 (1998) (describing the benefits and limitations of voluntary moratoriums).
91. Paul Berg, Asilomar 1975: DNA Modification Secured, 455 NATURE 290, 290 (2008).
92. 1953: DNA Double Helix, NAT’L HUM. GENOME RSCH. INST. (Apr. 23, 2013),
https://www.genome.gov/25520255/online-education-kit-1953-dna-double-helix.
93. See Berg, supra note 91(describing the concerns and possibilities surrounding recombinant
DNA in the 1970s).
94. Leslie Pray, Recombinant DNA Technology and Transgenic Animals, 1 NATURE EDUC. 51, 51
(2008).
95. Recombinant DNA Technologies and Researchers’ Responsibilities, 1973–1980, U.S. NAT’L
LIBR. OF MED., https://profiles.nlm.nih.gov/spotlight/cd/feature/dna (last visited Apr. 7, 2021).
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sensational stories. 96 The resulting Committee on Recombinant DNA Molecules
in 1974 recommended that all recombinant DNA experiments cease. 97 The
Committee stated it was “most important, that until the potential hazards of such
recombinant DNA molecules have been better evaluated or until adequate
methods are developed for preventing their spread, scientists throughout the
world [should] join with the members of this committee in voluntarily deferring”
these experiments. 98 The Committee also recommended that an international
conference could be held to create guidelines for moving forward. 99 This
recommendation, as well as two others, was adopted by the National Academy
of Sciences and the now-famous Asilomar conference followed in 1975. 100
Concerns about researcher and environmental safety, containment, and
other related issues drove the effort, which was sensitive also to how the press
and negative public perception could threaten the nascent field. 101 A consensus,
of sorts, arose around a set of guidelines to govern this type of research; and the
first iteration of the NIH-sponsored, independent advisory committee to the
Director of the NIH, the Recombinant DNA Advisory Committee (“RAC”), met
the same day that meeting closed. 102 It passed the Asilomar group’s statement
as a provisional set of standards to govern federally funded research in this
field. 103 The agreements reached at the Asilomar conference were not
substantively relaxed until the end of 1978. 104
Perhaps one of the most immediate results of the moratorium and Asilomar
conference was the allaying of fears in the public perception. The moratorium
may well have helped calm nerves related to science-gone-wrong nightmare
scenarios depicted in the media at the time. The Asilomar conference
specifically included a significant number of media personnel in attendance
under an agreement of non-publication until after the conference was over. 105
Immediate media coverage of the Asilomar conference recommendations was

96. See Berg, supra note 91.
97. Paul Berg et al., Potential Biohazards of Recombinant DNA Molecules, 71 PROC. NAT. ACAD.
SCI. 2593, 2593-94 (1974).
98. Id.
99. Id.
100. See Berg, supra note 91.
101. Paul Berg et al., Summary Statement of the Asilomar Conference on Recombinant DNA
Molecules, 72 PROC. NATL. ACAD. SCI. 1981, 1981–84 (1975).
102. Nelson A. Wivel, Historical Perspectives Pertaining to the NIH Recombinant DNA Advisory
Committee, 25 HUM. GENE THERAPY 19, 19 (2014).
103. See Donald S. Frederickson, Alisomar and Recombinant DNA: The End of the Beginning, in
BIOMEDICAL POLITICS 258–98 (Kathi E. Hanna ed.,1991) (providing a terrific summary of the Asilomar
group’s meeting and its aftermath).
104. Id. at 283.
105. Id. at 274.
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positive. 106 In combination, this moratorium and deliberative conference may
have helped pave the way for public and scientific acceptance of research for
which there was significant safety, ethics, or other concern.
The moratorium on recombinant DNA research and the principles debated
during the Asilomar conference have had long-standing impact. Elements were
found in the original NIH guidelines that govern the use of recombinant DNA
technology introduced in the 1990s. 107 The NIH Guidelines included
prohibitions on certain types of research (e.g., cloning) and evolved over time as
knowledge expanded around risks and benefits. 108 Additionally, over time the
RAC introduced a formal review system for studies involving insertion of new
genes into humans; RAC approval was required before the FDA would consider
any gene therapy proposal. 109 Thus, what was a limitation driven purely by
community consensus became a more refined, and narrowed limitation through
an executive branch policy. 110
The RAC continued to function for decades after its creation, but in 2019
NIH finalized its revised Guidelines. 111 In it, it eliminated human gene transfer
protocol approval by the RAC and modified the committee’s scope and focus to
better align with the changing landscape of research, namely, that recombinant
DNA research was no longer an emerging technology that required such strict
oversight. 112 The story of the Asilomar conference, its recommendations, and
the RAC’s work decades later is a testament to the positive impact a voluntary
moratorium can have to focus attention and resources toward a common goal to
address ethical and safety questions that arise with emerging technology.

106. JOHN LEAR, RECOMBINANT DNA: THE UNTOLD STORY 115–18 (Crown Publishing, 1st ed.,
1978).
107. Frederickson, supra note 103, at 283–84.
108. See Bernard Talbot, Development of the National Institutes of Health Guidelines for
Recombinant DNA Research, 98 PUB. HEALTH REP. 361, 363–66 (1983) (discussing the history of NIH
Guidelines on Recombinant DNA research into the early 1980s).
109. INST. MED., OVERSIGHT AND REVIEW OF CLINICAL GENE TRANSFER PROTOCOLS: ASSESSING
THE ROLE OF THE RECOMBINANT DNA ADVISORY COMMITTEE 47 (Rebecca N. Lenzi et al. eds., 2014).
110. NAT’L INST. OF HEALTH, Vol. 5, No. 20, 1–26, GUIDE FOR GRANTS AND CONTRACTS DNA
RECOMBINANT RESEARCH (1976); see also Meredith Wadman, U.S. Biologists Adopt Cloning
Moratorium, 389 NATURE 319, 319 (1997) (providing another example of community consensus rising
to limit research in the voluntary moratorium on cloning that research societies adopted following
recommendations from the National Bioethics Advisory Committee in 1997).
111. NAT’L INST. OF HEALTH, NOTICE OF THE PUBLICATION OF REVISED NIH GUIDELINES FOR
RESEARCH INVOLVING RECOMBINANT OR SYNTHETIC NUCLEIC ACID MOLECULES (2019).
112. Id.
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b. Germline Gene Editing
Heritable germline editing is the process by which a person’s genes are
edited in such a way that the change may be inherited by offspring. 113 In March
2019, the NIH Director joined other 17 senior leaders from the biomedical and
public advocacy communities across the globe in a commentary in Nature calling
for a “moratorium on all clinical uses of . . . heritable genome editing” in humans
to make genetically modified children. 114 The authors of this proposed
moratorium included Paul Berg of Asilomar fame (who was one of the primary
drivers of that effort). 115
The call for a moratorium was driven by several concerns:
•

The announcement that CRISPR-Cas9 had been used by a
scientist in the People’s Republic of China to induce heritable
changes in two human babies.

•

Other scientists were aware of the effort in China and did not
“take adequate measures to stop it.”

•

The authors cited and increased interest in genetically
modifying humans.

•

Apparent confusion or mixed signals sent by different
agencies in the U.S. government related to human genetic
editing.

•

An absence of a proper mechanism to stimulate international
dialogue on appropriate clinical germline editing. 116

The NIH Director’s action in joining his colleagues in Nature is different from
the NIH activities discussed above because the NIH Director did not follow the

113. See Josephine Johnston, The U.S. Must Do Some Heavy Lifting to Prepare for Heritable
Genome Editing, STAT NEWS (Sep. 4, 2020), https://www.statnews.com/2020/09/04/heritable-genomeediting-will-require-heavy-lifting-us-policy/ (discussing heritable genome editing and how it challenges
U.S. health and technology policy).
114. Eric Lander et al., Adopt a Moratorium on Heritable Genome Editing, 567 NATURE 165, 165
(2019).
115. See Frederickson, supra note 103, at 265–83 (discussing the Asilomar Conference and Paul
Berg’s influence).
116. Jocelyn Kaiser & Dennis Normille, Embryo Engineering Study Splits Scientific Community,
SCI. MAG., May 2015 at 486.
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paper with any specific executive policy limit on NIH research funding. 117 Such
a policy is not needed, of course, because there is already a legislative
moratorium in place in the U.S. to prohibit this type of research. 118 In December
2015, Congress barred the FDA from considering clinical trials “in which a
human embryo is intentionally created or modified to include a heritable genetic
modification.” 119 This includes mitochondrial DNA transfer, used to address
some inherited diseases, for which there is concern and controversy from those
wishing to see cures. 120 The ban is broader than any NIH funding limitation,
including the Dickey-Wicker Amendment.
A few other things are worth examining in the Nature piece. First, the
authors emphasize that they are seeking a global consensus of when germline
editing in humans will be permitted and a framework for the same. 121 They state:
By “global moratorium”, we do not mean a permanent ban. Rather,
we call for the establishment of an international framework in which
nations, while retaining the right to make their own decisions,
voluntarily commit to not approve any use of clinical germline editing
unless certain conditions are met. 122
As such, a moratorium is proposed as a way to create some breathing space, room
for the international community to seek consensus over when and how so
fundamental a process as human germline editing should be allowed.
Interestingly, like many moratoria before this, the authors lead with a focus on
science. 123 They discuss first “technical considerations,” then “scientific
considerations,” followed by “medical considerations,” for a total of about 22
paragraphs, and then they add three paragraphs on “societal, ethical and moral
considerations.” 124 This is not to suggest the authors do not recognize the serious
ethical concerns at issue. Paragraph one of the three-paragraph “ELSI” subpart
states:
Irrespective of all of the above, clinical germline editing should not
proceed for any application without broad societal consensus on the
appropriateness of altering a fundamental aspect of humanity for a
117. NAT’L INST. OF HEALTH, supra note 111.
118. Emily Mullin, Patient Advocates and Scientists Launch Push to Lift Ban on “Three-Parent
IVF”, STAT NEWS (Apr. 16, 2019), https://www.statnews.com/2019/04/16/mitochondrial-replacementthree-parent-ivf-ban/.
119. Id.
120. Id.
121. Lander et al., supra note 114.
122. Id.
123. Id. at 166.
124. Id.

04 BONHAM (DO NOT DELETE)

2021]

12/17/2021 9:22 AM

MORATORIA IN SCIENTIFIC RESEARCH

241

particular purpose. Unless a wide range of voices are equitably
engaged from the outset, efforts will lack legitimacy and might
backfire. 125
But the rest of this section includes a distinctly consequentialist bent:
The societal impacts of clinical germline editing could be
considerable. Individuals with genetic differences or disabilities can
experience stigmatization and discrimination. Parents could be put
under powerful peer and marketing pressure to enhance their children.
Children with edited DNA could be affected psychologically in
detrimental ways. Many religious groups and others are likely to find
the idea of redesigning the fundamental biology of humans morally
troubling. Unequal access to the technology could increase inequality.
Genetic enhancement could even divide humans into subspecies.
Moreover, the introduction of genetic modifications into future
generations could have permanent and possibly harmful effects on the
species. These mutations cannot be removed from the gene pool
unless all carriers agree to forgo having children, or to use genetic
procedures to ensure that they do not transmit the mutation to their
children. 126
As illustrated by this example, ethics can and may need to be the driving force
behind a moratorium, but oftentimes questions about safety, technical feasibility,
and physical risks rise to the fore and become a dispositive way to side-step more
complex and, sometimes, seemingly intractable problems.
c. Rejected Moratorium on Xenotransplants
Not all calls for moratoria are successful. In 1998, Professor Fritz Bach at
Harvard Medical School and others called for a moratorium on clinical
xenotransplant trials pending public debate on the risks. 127 Xenotransplantation
is the transplant of organs from one species to another. 128 Research in this area
dates back to the 17th century but in modern times, xenotransplantation attempts
were underway starting in the mid-1960s. 129 Over decades, researchers
125. Id. at 167.
126. Id.
127. Interview with Fritz Bach, Professor, Harvard Med. Sch. (transcript available at
https://www.pbs.org/wgbh/pages/frontline/shows/organfarm/interviews/bach.html).
128. Xenotransplantation, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/vaccines-bloodbiologics/xenotransplantation (last visited May 1, 2021).
129. History of Xenotransplantation Experiments, PBS FRONTLINE,
https://www.pbs.org/wgbh/pages/frontline/shows/organfarm/etc/cron.html (last visited Apr. 8, 2021).
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attempted to use organs of animals as replacements for missing or failing human
organs. 130 For example, in 1963 Dr. Keith Reemtsma transplanted 13
chimpanzee kidneys into 13 humans; most died shortly afterwards but one patient
lived for another nine months with medical assistance. 131 In 1995, Dr. Suzanne
Ilstaad transplanted bone marrow from a baboon into a patient living with
AIDS. 132 Baboon stem cells are resistant to AIDS; researchers hoped the
transplantation would help the patient’s bone marrow produce AIDS-fighting
immune cells. 133 The attempt was not successful. 134
Professor Bach’s call for a moratorium by the FDA however fell on deaf
ears. FDA did not institute a moratorium, perhaps because a year earlier, in 1997,
the FDA reacted to a researcher’s alarming discovery; Professor Robin Weiss
discovered a virus embedded in every pig cell, referred to as “PERV,” could
infect human cells. 135 Pig organs and cells had long been used in
xenotransplantation experiments, so Dr.Weiss’ discovery was distressing. In
response, the FDA did place a moratorium on all clinical trials until researchers
could prove they had developed procedures to detect low levels of PERV virus
infection. 136 The FDA was satisfied by January 1998 and lifted the
moratorium. 137
However, Professor Bach still believed there should be a moratorium. He
stated:
[W]e should have a moratorium to allow the public discussion, to
allow the public to be informed – as many people as possible – and to
have segments of that public participate in what is known as public
engagement, public deliberation, to help guide us in how to play. And
as soon as they’ve helped us and we can define the conditions of how
to proceed, then we should drop the moratorium, and, if we’re ready
to do it, move ahead with xenotransplantation. 138
Professor Bach was particularly frustrated with the FDA’s existing review
process. He argued that existing FDA open hearings were inadequate to address
public concerns and hear public input:

130.
131.
132.
133.
134.
135.
136.
137.
138.

Id.
Id.
Id.
Id.
Id.
Id.
Id.
Id.
Interview, supra note 127.
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[A] person would have to know the hearing is taking place, pay their
way to Bethesda, Maryland, and then try to get time to speak. I went
down there. I think I’m a rather prominent individual in
xenotransplantation, and I was told that I couldn’t speak from the
podium, that I should speak from the floor, and keep it very brief.
That’s very difficult; it’s not a way to get public participation. There’s
been a lot of coverage in the news, but it hasn’t been in a way to catch
the public’s attention. If you ask the vast majority of people, they still
say, “What are you talking about?” 139
Professor Bach’s unsuccessful drive to have a moratorium to address public
concerns regarding xenotransplantation is informative in several respects. First,
executive policy moratoria are difficult to institute by non-executive branch
actors. Professor Bach was calling for an executive policy moratorium by the
FDA although he held no particular influence or formal position at the agency.
Second, voluntary moratoria may be successfully instituted when advocated by
the right persons. When the Director of the NIH and researchers from countries
around the globe called for a voluntary moratorium on heritable human gene
editing, the call was effective due to the prominence of the authors combined
with the nature of the moratorium – it was voluntary. 140 Third, moratoria may
be more likely to be instituted where government or community action has not
already begun. The FDA had set a moratorium that was lifted the same year
Professor Bach called for a new one. Meanwhile, the FDA had already
undertaken a review and public feedback process, one in which reasonable minds
can differ when analyzing the extent the moratorium was sufficient or
appropriate for the issue.
V. CONCLUSION
In 2010, the Presidential Commission for the Study of Bioethical Issues did
not recommend a moratorium for any applications of the emerging technology
of synthetic biology. 141 The Commission members did offer an ethical
framework for assessing emerging technologies that included recommendations
about safety and feasibility and they emphasized transparency, public
engagement, and accountability. 142 This framework provided an effective
139. Id.
140. Lander, supra note 114; Wadman, supra note 110.
141. PRESIDENTIAL COMM’N FOR THE STUDY OF BIOETHICAL ISSUES, NEW DIRECTIONS: THE
ETHICS OF SYNTHETIC BIOLOGY AND EMERGING TECHNOLOGIES V (2010) (finding no reason to endorse
additional federal regulations or a moratorium on synthetic biology, and instead recommending an
ongoing review of possible developments, risks, opportunities and oversight grounded in ethical
principles of public beneficence, responsible stewardship, intellectual freedom and responsibility,
democratic deliberation, and justice and fairness).
142. Id. at 4, 6, 9, 10.

04 BONHAM (DO NOT DELETE)

244

JOURNAL OF HEALTH CARE LAW & POLICY

12/17/2021 9:22 AM

[VOL. 24:2

method to manage public concerns and political; concerns. 143 Further, the lack
of moratorium helped assure the continuation of scientific research into the
emerging technology.
Calls for moratoria in biomedical research are not all that common, but they
recur with some regularity. Moratoria can range from voluntary, communitybased action to mandatory, executive policy or legislatively-based requirements.
The examples discussed here illustrate a range of approaches. What do they
suggest about why moratoria are established in the first place?
Almost all moratoria are inspired by a public fear or a need to preempt
public fear of new techniques or emerging technologies. Given this motivation,
it is important to recognize that the parameters, timing, and source of a
moratorium can have profound impact on the public’s perception of the
technique or technology, and further, impact the ease with which the moratorium
may be unwound. An approach that is policy-based, rather than legislative, is
more flexible and essentially beholden to fewer constituents. Thus, it may be
easier to change or refine over time as ethical concerns abate or wane. However,
as the examples described here reflect, even these efforts may be difficult to
unwind as circumstances change.
Further, moratoria can, and almost always are, to some degree, motivated
by politics and the desire to respond to public concerns that may be fractured and
inconsistent. In many instances, partisan political and social positions can drive
government actors to adopt moratoria that change with the coming and going of
presidential administrations and congressional sessions. But often, once adopted
as a legislative mandate, moratoria may remain in place even after the scientific
community and emerging technology may have matured. This is because
removing them is often more difficult than avoiding them in the first instance.

143. Amy Gutmann, The Ethics of Synthetic Biology: Guiding Principles for Emerging
Technologies, 41 HASTINGS CTR. REP. 17, 22 (2011); see also PRESIDENTIAL COMM’N FOR THE STUDY
OF BIOETHICAL ISSUES, supra note 141, at 152–53.

04 BONHAM (DO NOT DELETE)

2021]

12/17/2021 9:22 AM

MORATORIA IN SCIENTIFIC RESEARCH

245

Appendix – Selected MoratoriaThe below chart provides a selection of
moratoria on scientific research activities. These moratoria may be based on
statutory requirements, executive policy, or community consensus. The chart is
not intended to be a complete list of all moratoria.
Throughout this chart the following acronyms are used:
• EOP: Executive Office of the President
• HHS: Department of Health and Human Services
• IVF: In Vitro Fertilization
• NIH: National Institutes of Health
Year

1973

Subject

Origin &
Structure

Stem Cell

HHS

Research 144

(Regulatory)

Scope
Prohibited NIH from
funding research using
live human embryos.

Timeline
1973 –
1975

Type

Mandatory

Penalty
Loss of
Funds

Moratorium on federally
funded clinical research on
embryos and embryonic
1974

Stem Cell

Congress

Research 145

(Statutory)

tissue, including research
on IVF, infertility, and

1974Present

Mandatory

Loss of
Funds

prenatal diagnosis, until
national guidelines could
be established.
Prohibited research on a
fetus from an elective
abortion until the National
1974

Fetal Tissue 146

Congress
(Statutory)

Commission for
Protection of Human
Subjects in Biomedical

1974 –
1975 147

Mandatory

Loss of
Funds

and Behavioral Research
completed its report to
Congress in 1975.

144. Christopher R. Cogle et al., An Overview of Stem Cell Research and Regulatory Issues, 78
MAYO CLINIC PROC. 993, 999 (2003); THE PRESIDENT’S COUNCIL ON BIOETHICS, MONITORING STEM
CELL RESEARCH (2004),
https://bioethicsarchive.georgetown.edu/pcbe/stemcells/chapter2_mon_research.html#edn1 (last visited
May 18, 2021).
145. National Research Act, Pub. L. No. 93-348, § 213, 88 Stat. 342 (passed by the 93rd Congress as
H.R. 7724, July 12, 1974).
146. Id. § 202(3)(b).
147. In effect, this moratorium continued until 1993.
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Subject

Origin &

Recombinant
1975

Scope

Structure

DNA

Community

Experimentation

(Consensus)

148

Timeline

[VOL. 24:2
Type

A moratorium on certain
recombinant DNA

1975

Voluntary

experiments.

Penalty

Community
Censure

A moratorium on issuing
1985

Fetal Tissue 149

Congress
(Statutory)

waivers for fetal research;
only research involving
minimal risk or for

1985 –
1988

Mandatory

Loss of
Funds

therapeutic purposes.
A moratorium on
transplantation research
with fetal tissue from
induced abortions until the
1988

Fetal Tissue 150

HHS

Human Fetal Tissue

(Regulatory) Transplantation Research

1988 –
1993

Mandatory

Loss of
Funds

Panel issued its report –
which it did in December
1988. HHS extended the
moratorium afterwards.
Prohibits HHS using
appropriated funds for the
creation of human
embryos for research
purposes or for research in
1996

Dickey Wicker

Congress

Amendment 151

(Statutory)

which human embryos are

1996 –

destroyed, discarded, or

Present

knowingly subjeted to risk

Loss of
Mandatory

Funds;
Other

of injury or death greater
than that allowed for
research on fetuses in
utero.

148. See Berg, supra note 91, at 291.
149. Health Research Extension Act, Pub. L. No. 99-158, § 498, 99 Stat. 820 (1985).
150. Setting the Stage: Fetal Research, Fetal Tissue Research, and Historical Timeline of Regulation
and Legislation, in INST. OF MED. CONFERENCE COMM. ON FETAL RESEARCH AND APPLICATIONS,
(Nat’l Acad. Press 1994) (ebook); Federal Funding of Fetal Tissue Transplantation Research, 58 Fed.
Reg. 7457 (Feb. 5, 1993) (memorandum from President Clinton to the Secretary of Health and Human
Services lifting the moratorium on federal funding of fetal tissue research).
151. Pub. L. No. 104–99, § 128, 110 Stat. 26, 34 (1996).
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Stem Cell
Research 152

Origin &

EOP
(Executive
Poloicy)
United

2005

Human Cloning 153

Scope

Structure

Nations
(Consensus)

Timeline

247
Type

Penalty

Ban on federal funding for
research using ES cell
lines (embryos) derived

2001 –
2009

Mandatory

Loss of
Funds

after August 9, 2001.
Bans human cloning as
incompatible with human

2005–

dignity and the protection

Present

Voluntary

None

of human life.
A moratorium on any
research involving highly

Community pathogenic avian influenza 1/20/2012
2012

Avial Influenze 154 of Scientists H5N1 viruses leading to
(Consensus) the generation of viruses

–

Voluntary

None

2/1/2013

that are more transmissible
in mammals.
Prohibition on human2015

Human-Animal

NIH

Chimera 155

(Regulatory)

animal chimeras and
inheritable genome editing
in human embryos

9/2015 –
Present

Mandatory

Loss of
Funds

research funding.
A federal ban that
prohibited the use of
2015

Heritable Human

Congress

Gene Editing 156

(Statutory)

federal funds for research
involving genetically
modifying human

9/2015 –
Present

Mandatory

Loss of
Funds

embryos, which includes
MRT.

152. President George W. Bush, Address on Stem Cell Research at the Bush Ranch (Aug. 9, 2001)
(transcript available at https://georgewbush-whitehouse.archives.gov/news/releases/2001/08/200108092.html); NAT’L INST. OF HEALTH, NOTOD-02-005, NOTICE OF CRITERIA FOR FEDERAL FUNDING OF
RESEARCH ON EXISTING HUMAN EMBRYONIC STEM CELLS AND ESTABLISHMENT OF NIH HUMAN
EMBRYONIC STEM CELL REGISTRY (2001).
153. General Assembly Approves Declaration Banning All Forms of Cloning, U.N. NEWS (Mar. 8,
2005), https://news.un.org/en/story/2005/03/131092-general-assembly-approves-declaration-banningall-forms-cloning.
154. Ron A.M. Fouchier et al., Pause on Avian Flu Transmission Studies, 481 NATURE 443, 443
(2012).
155. NAT’L INST. OF HEALTH, NOT-OD-15-158, NIH RESEARCH INVOLVING INTRODUCTION OF
HUMAN PLURIPOTENT CELLS INTO NON-HUMAN VERTEBRATE ANIMAL PRE-GASTRULATION EMBRYOS
(2015).
156. Pub. L. No. 114–113, § 749, 129 Stat. 2242 (2015).
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Subject

Origin &

Scope

Structure

Chimpanzees for

NIH

Biomedical

(Executive

Research 157

Policy)

Prohibits use of
chimpanzees in NIH
funded research.

Timeline
2015 –
Present

[VOL. 24:2
Type

Mandatory

Penalty
Loss of
Funds

A moratorium on all
NIH
2019

Heritable Human
Gene

Editing 158

Directorand
scientists in
seven
countries

clinical uses of human
germline editing
(changing heritable DNA
in sperm, eggs or

2019

Voluntary

Community
Censure

embryos) to make
genetically modified
children.
Fetal tissue research ban

2019

Fetal Tissue
Research 159

EOP, HHS

on scientists at NIH and

June 5,

(Executive

on funding of new and

2019 –

renewed extramural

Present.

Policy)

Mandatory

Loss of
Funds

research grants.

157. Francis S. Collins, NIH Will No Longer Support Biomedical Research on Chimpanzees, NAT’L
INST. OF HEALTH (Nov. 17, 2015), https://www.nih.gov/about-nih/who-we-are/nihdirector/statements/nih-will-no-longer-support-biomedical-researchchimpanzees#:~:text=On%20June%2016%2C%202015%2C%20the,it%20could%20harm%20the%20a
nimal.
158. Eric Lander et al., supra note 114; Carrie D. Wolinetz & Francis S. Collins, NIH Pro Germline
Editing Moratorium, 567 NATURE 175, 175 (2019) (endorsing the international moratorium proposed by
Eric Lander and other scientists within the international community).
159. Meredith Wadman, Trump Administration Restricts Fetal Tissue Research, SCIENCE (Jun. 5,
2019), https://www.sciencemag.org/news/2019/06/trump-administration-restricts-fetal-tissue-research;
NAT’L INST. OF HEALTH, NOT-OD-21-111, UPDATE ON CHANGES TO NIH REQUIREMENTS REGARDING
PROPOSED HUMAN FETAL TISSUE RESEARCH (2021).

